Olivier Martinez holds a PhD in cell biology from the University of Paris XI and a diploma from the Collège des Ingénieurs.
From 1992 to 1997, Olivier Martinez pursued his doctoral studies in cell biology at the Pasteur and Curie Institutes in Paris. After undergoing management training, he joined the Life Science Group of Gemini Consulting and spent two years working on healthcare projects.
In 2000, he joined Bioam Gestion as an Associate and became Investment Manager and member of the executive board in 2004.
Following the integration of Bioam Gestion into CDC Entreprises in July 2010, he is now in charge of managing investments of the InnoBio and Bioam funds.
Olivier is a graduate of the Ecole Normale Supérieur (Ulm).